| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.6M | -31.1% | -75.2% |
| SG&A Expense | $4.0M | +0.3% | -10.0% |
| Operating Income | -$7.6M | +17.4% | +59.7% |
| Pre-tax Income | -$7.4M | +22.1% | +58.0% |
| Income Tax | $0 | — | — |
| Net Income | -$7.4M | +22.1% | +58.0% |
| EPS (Basic) | -$0.60 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $49.0M | -10.6% | -44.9% |
| Current Assets | $50.8M | -12.9% | -45.9% |
| Total Assets | $57.8M | -12.6% | -44.7% |
| Current Liabilities | $11.1M | -3.7% | -22.8% |
| Total Liabilities | $76.2M | -2.7% | -11.6% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.4M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | -$1.6M | — | — |
| Free Cash Flow | -$27.4M | — | — |
| +58.9% |
| EPS (Diluted) | -$0.60 | +23.1% | +58.9% |
| -$18.4M |
| -50.8% |
| -200.8% |